You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/116577
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAndreani, Tatiana-
dc.contributor.authorSouza, Ana Luiza R. de-
dc.contributor.authorKiill, Charlene P.-
dc.contributor.authorLorenzon, Esteban N.-
dc.contributor.authorFangueiro, Joana F.-
dc.contributor.authorCristina Calpena, Ana-
dc.contributor.authorChaud, Marco V.-
dc.contributor.authorGarcia, Maria L.-
dc.contributor.authorGremiao, Maria Palmira D.-
dc.contributor.authorSilva, Amelia M.-
dc.contributor.authorSouto, Eliana B.-
dc.date.accessioned2015-03-18T15:53:32Z-
dc.date.accessioned2016-10-25T20:25:07Z-
dc.date.available2015-03-18T15:53:32Z-
dc.date.available2016-10-25T20:25:07Z-
dc.date.issued2014-10-01-
dc.identifierhttp://dx.doi.org/10.1016/j.ijpharm.2014.07.049-
dc.identifier.citationInternational Journal Of Pharmaceutics. Amsterdam: Elsevier Science Bv, v. 473, n. 1-2, p. 627-635, 2014.-
dc.identifier.issn0378-5173-
dc.identifier.urihttp://hdl.handle.net/11449/116577-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/116577-
dc.description.abstractThe present study reports the production and characterization of PEG-coated silica nanoparticles (SiNP-PEG) containing insulin for oral administration. High (PEG 20,000) and low (PEG 6000) PEG molecular weights were used in the preparations. SiNP were produced by sol gel technology followed by PEG adsorption and characterized for in vitro release by Franz diffusion cells. In vitro permeation profile was assessed using everted rat intestine. HPLC method has been validated for the determination of insulin released and permeated. Insulin secondary structure was performed by circular dichroism (CD). Uncoated SiNP allowed slower insulin release in comparison to SiNP PEG. The coating with high molecular weight PEG did not significantly (p>0.05) alter insulin release. The slow insulin release is attributed to the affinity of insulin for silanol groups at silica surface. Drug release followed second order kinetics for uncoated and SiNP PEG at pH 2.0. On the other hand, at pH 6.8, the best fitting was first-order for SiNP PEG, except for SiNP which showed a Boltzmann behavior. Comparing the values of half-live, SiNP PEG 20,000 showed a faster diffusion followed by Si-PEG 6000 and SiNP. CD studies showed no conformational changes occurring after protein release from the nanoparticles under gastrointestinal simulated conditions. (C) 2014 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipFundacao para a Ciencia e Tecnologia (FCT, Portugal)-
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.format.extent627-635-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectSilica nanoparticlesen
dc.subjectInsulinen
dc.subjectPEG adsorptionen
dc.subjectOral deliveryen
dc.subjectMathematic modelingen
dc.subjectHPLC validationen
dc.titlePreparation and characterization of PEG-coated silica nanoparticles for oral insulin deliveryen
dc.typeoutro-
dc.contributor.institutionUniv Tras Os Montes & Alto Douro-
dc.contributor.institutionUTAD-
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionFernando Pessoa Univ-
dc.contributor.institutionUniv Barcelona-
dc.contributor.institutionSorocaba Univ-
dc.description.affiliationUniv Tras Os Montes & Alto Douro, Dept Biol & Environm, UTAD, P-5001801 Vila Real, Portugal-
dc.description.affiliationUTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, Vila Real, Portugal-
dc.description.affiliationFernando Pessoa Univ UFP, Res Ctr Biomed CEBIMED, P-4249004 Oporto, Portugal-
dc.description.affiliationUniv Estadual Paulista, Dept Pharmaceut Sci, UNESP, Sao Paulo, Brazil-
dc.description.affiliationUniv Estadual Paulista, Inst Chem, UNESP, Dept Biochem & Chem Technol, Sao Paulo, Brazil-
dc.description.affiliationFernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal-
dc.description.affiliationUniv Barcelona, Sch Pharm, Pharm & Pharmaceut Technol Dept, Biopharm & Pharmacokicet Unit, Barcelona 8028, Spain-
dc.description.affiliationSorocaba Univ, UNISO, BR-18023000 Sorocaba, Brazil-
dc.description.affiliationUniv Barcelona, Fac Pharm, Dept Phys Chem, Barcelona 8028, Spain-
dc.description.affiliationUTAD, Ctr Genom & Biotechnol, Inst Biotechnol & Bioengn, Vila Real, Portugal-
dc.description.affiliationUnespUniv Estadual Paulista, Dept Pharmaceut Sci, UNESP, Sao Paulo, Brazil-
dc.description.affiliationUnespUniv Estadual Paulista, Inst Chem, UNESP, Dept Biochem & Chem Technol, Sao Paulo, Brazil-
dc.description.sponsorshipIdFundacao para a Ciencia e Tecnologia (FCT, Portugal)SFRH/BD/60640/2009-
dc.description.sponsorshipIdFundacao para a Ciencia e Tecnologia (FCT, Portugal)SFRH/BD/80335/2011-
dc.description.sponsorshipIdFAPESP: 12/10174-3-
dc.identifier.doi10.1016/j.ijpharm.2014.07.049-
dc.identifier.wosWOS:000342656800069-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofInternational Journal Of Pharmaceutics-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.